calcium acetate has been researched along with vitamin d 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Martin, CJ; Reams, SM | 1 |
| Drüeke, TB; Landais, P | 1 |
| Gotch, F; Kotanko, P; Levin, NW | 1 |
2 review(s) available for calcium acetate and vitamin d 2
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
Topics: Acetates; Algorithms; Bone Density Conservation Agents; Calcitriol; Calcium; Calcium Compounds; Calcium Metabolism Disorders; Calcium, Dietary; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Ergocalciferols; Homeostasis; Humans; Intestinal Absorption; Kidney Failure, Chronic; Models, Biological; Phosphorus; Practice Guidelines as Topic; Reference Values; Renal Dialysis; Research Design; Ultrafiltration | 2010 |
2 other study(ies) available for calcium acetate and vitamin d 2
| Article | Year |
|---|---|
The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey.
Topics: Acetates; Bone and Bones; Calcium Carbonate; Calcium Compounds; Dietetics; Epoxy Compounds; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Phosphates; Phosphorus, Dietary; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2003 |
Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients.
Topics: Acetates; Calcitriol; Calcium; Calcium Compounds; Chronic Disease; Cinacalcet; Clinical Trials, Phase III as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic | 2006 |